Phase 2 Addiction Clinical Trials
11 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–11 of 11 trials
Recruiting
Phase 2
Semaglutide Therapy for Alcohol Reduction (STAR)
Alcohol Use DisorderAddiction
National Institute on Drug Abuse (NIDA)67 enrolled1 locationNCT06015893
Recruiting
Phase 2
Accelerated dTMS Smoking Cessation
Tobacco Use DisorderAddiction Nicotine
Waypoint Centre for Mental Health Care40 enrolled2 locationsNCT07292883
Recruiting
Phase 2
A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence
AlcoholismAlcohol Addiction
Central Institute of Mental Health, Mannheim150 enrolled2 locationsNCT06845124
Recruiting
Phase 2
The CONQUER Trial - Cessation Of Nicotine, QUitting With E-cigarette Reduction
Addiction Nicotine
VapeAway70 enrolled1 locationNCT07322432
Recruiting
Phase 2
Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis
Smoking (Tobacco) AddictionPancreatitis, ChronicRecurrent Acute Pancreatitis+1 more
Mayo Clinic45 enrolled1 locationNCT07171112
Not Yet Recruiting
Phase 2
A Novel Opioid Treatment Program In Individuals With An Opioid Use Disorder
Opioid DependenceAddiction
Western Sydney Local Health District Drug Health45 enrolled1 locationACTRN12621000899842
Suspended
Phase 2
A randomised (non-blinded) trial comparing the clinical efficacy of naltrexone implant plus Cognitive Behavioral Therapy versus Cognitive Behavioral Therapy in the management of problem amphetamine use
Amphetamine addiction
Go Medical Industries Pty Ltd60 enrolled1 locationACTRN12618000568213
Completed
Phase 2
A Single-Center, Open-Label Pharmacokinetic (PK) Study to Assess the PK Profile of Nicotine Delivered by the Chrono Quit Smoking Solution (CQSS2)
cigarette addiction
Chrono Therapeutics Australia PTY LTD10 enrolled1 locationACTRN12617001258347
Recruiting
Phase 2
The effect of baclofen on methamphetamine dependent subjects.
Methamphetamine Addiction
Linear Clinical Research Ltd18 enrolled1 locationACTRN12616001614482
Completed
Phase 2
A Two-Arm, Open-Label, Multi-Location, Single Center Study of the Craving Profile of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2; 21 mg) versus NiQuitin (registered trademark) Patch (21 mg) for Smoking Cessation in Treatment Seeking Subjects
cigarette addiction
Chrono Therapeutics Australia PTY LTD85 enrolled1 locationACTRN12616001529437
Completed
Phase 2
A Single-Center, Randomized, Open-Label, Two-Period, Cross Over, Pharmacokinetic Study to Assess the Relative Bioavailability of Nicotine Delivered by the Chrono Quit Smoking Solution (CQSS1) versus NicoDerm (Registered Trademark) CQ (Registered Trademark) Patch
cigarette addiction
Chrono Therapeutics Australia PTY LTD32 enrolled1 locationACTRN12616000824460